About Broadstreet HEOR
We are an independent consultancy specializing in epidemiology and health economics, with a particular focus on creating customized solutions to best meet our clients’ diverse needs. Our team comprises of epidemiologists, health economists, statisticians, and IT specialists. Our projects are led by senior team members with extensive experience leading the kinds of HEOR studies at which Broadstreet excels. We have a ready pool of clinical collaborators and data holders for real-world studies; and offer a package of integrated service offerings with our core areas of expertise:
Economic models grounded in robust, realist evidence synthesis
Epidemiologic and statistical modelling
Quantitative and qualitative patient and physician interviews
We work well with others
We are not a large company with an interchangeable and revolving roster. We are a small office, the core of which has worked together for more than 15 years. We enjoy working with each other and pride ourselves on our strength in collaborating with others. We conduct business on human terms, not term sheets.
We only do work we’re best at
We focus on what we know how to do very well. We specialize in building economic models, conducting literature reviews and evidence syntheses, designing and implementing database studies, and conducting retrospective and prospective observational studies and surveys focusing on epidemiology, treatment patterns, outcomes and preferences. In addition, we have created a number of customizable mobile applications to help clients demonstrate the value of their products.
We’re honest and transparent
Project management and scientific rigour — clients tell us we’ve mastered what is both art and science. We’re honest and transparent right from project definition stage through to completion. We keep open lines of communication. We include the client as part of our project team. Most importantly, we do not believe in Big Surprises.
We’re invested in whom we work with
We really care about our projects – it’s the first thing we tell anyone we work with, and that is what we hear back from them. We have very many long standing relationships with clients that are important to us. And with new clients, we ensure we give each project the attention it deserves, so they want to work with us again.
We deliver as promised
Clients trust us. Our client service approach is simple: whatever the problem, no matter how difficult or time constrained, we will have a rigorous solution and deliver – as promised.
We are a small office, the core of which has worked together in HEOR for more than 15 years. We enjoy working with each other and pride ourselves on our strength in collaborating with others. We conduct business on human terms, not term sheets.
Our larger team comprises epidemiologists, health economics, biostatisticians, and programmers. Specifically, this includes research directors, a senior business director, systematic reviewers and analysts. We also have an in-house data services team that includes database administrators, programmers, and an interface designer.
Meet our key team members
CEO and Scientific Director
For me, the perfect fit is a small business consultancy framework where I can work closely with colleagues I enjoy, and clients I like, on interesting research projects. I’m trained in epidemiology and have 15 years of experience in health outcomes research and consulting. Prior to Broadstreet, I was a Principal at ICON plc and the Head of the Epidemiology team; and the Head of Evidence Generation at Redwood Outcomes. My research interests are in pharmacoepidemiology, observational studies, burden of illness, preferences and methodologies to estimate competing benefits and risks. I’ve conducted studies in the areas of oncology, infectious diseases, rheumatology, diabetes, pediatrics, ophthalmology, and pain management; and my work has been published in journals including the Journal of Pediatrics, Annals of Hepatology, Arthritis & Rheumatism, British Journal of Cancer, Investigative Ophthalmology & Visual Sciences, Clinical Pediatrics, and Value in Health. In addition to the scientific aspect of our work, I also like the business aspects; including leading the research team, liaising with existing and potential clients, developing and implementing new initiatives that can meet our clients’ needs, and ultimately ensuring our clients’ satisfaction.
Karissa Johnston, PhD
Principal and Scientific Director
I love working as a consultant in HEOR. I enjoy the fast pace, the variety of studies we have a chance to work on, the ongoing collaborations with clients and experts, and the ability to maintain a “hands-on” role in academic research and analysis. I have a MSc. in statistics and a PhD in epidemiology. In addition to my full-time role as a Principal at Broadstreet, I have an adjunct appointment at Memorial University. As a consultant, my experience includes the development of cost-effectiveness and budget impact models; analysis of administrative, chart review, and trial data; retrospective study design; evidence synthesis; and patient preference studies such as discrete choice experiments. I have worked across a wide range of therapeutic areas, and have published articles in journals such as AIDS, Lancet Infectious Diseases, BMC Pediatrics, the European Journal of Cancer, and Value in Health.
Principal and Managing Director
My skill set is to create and sustain organizations that empower employees to serve clients. Over the last 25 years, I have been helping public and private organizations grow and succeed this way. After several senior management positions, I have returned to my preferred setting: leading a small HEOR company made up of people I count as both friends and colleagues. As a senior health services and health research leader and manager, I have years of executive, P&L and M&A responsibility. I have formal education in Business and community health and health services administration.
This year, Broadstreet’s Karissa Johnston will be moderating an issue panel on the topic of single-arm trials for novel therapies. The session: Single-arm trials of novel therapies. Too good for approval, but not good enough for reimbursement? will be […]
New techniques in data visualization are revealing connections and relationships that were previously hard to perceive. —— It feels like everyone is talking about data visualization at the moment. In health economics and outcomes research (HEOR), the focus is on […]
Broadstreet is off to Barcelona for this year’s ISPOR Europe conference, November 10th to 14th. We’ll be more than happy to spend a few days taking in Gaudí’s architectural marvels, eating tiny sandwiches, drinking coffees in leafy squares…and of course, […]